Forrest Li, Sea Limited chairman and group CEO, speaks with CNBC’s “Squawk Alley” about his company’s trading debut at the NYSE. » Read More
Jim Cramer caught up with Winnebago Industries CEO Michael Happe to hear the latest on people embracing the "RV lifestyle." » Read More
Josh Bolten, Business Roundtable president and CEO, discusses the budget vote in the Senate and what it means for the future of tax reform. » Read More
Okta CEO Todd McKinnon discusses the challenges with balancing customers' needs and achieving data security.
Fred Hassan, Warburg Pincus Managing Director and CNBC Contributor, talks about tax inversions in the pharmaceutical industry and his advice to Pfizer after its deal with Allergan fell through.
CNBC's David Faber looks at the Staples/Office Depot antitrust case, the Williams lawsuit against ETE and ETP CEO Kelcy Warren, and whether the Halliburton/Baker Hughes deal will go to court.
Merck CEO Kenneth Frazier talks with CNBC's Meg Tirrell about his company's avoidance of tax inversion deals, as well as his views on the M&A environment and drug pricing.
"You walk in and are overwhelmed by the work that needs to be done and how bad it has gotten," said one potential buyer.
Discussing how moves like the Treasury's new tax inversion rules could affect mergers and acquisitions going forward with Martin Okner, SHM Corporate Navigators Managing Partner, and Nicholas Fortuna, Partner at Allyn & Fortuna
Discussing the Justice Department's suit to block the deal between Baker Hughes and Halliburton, with Brian Uhlmer, GMP Securities.
The Pfizer, Allergan merger effort has reignited a debate over corporate inversions, says Yevgeniy Feyman. But US jobs are not really at stake.
CNBC contributors Jared Bernstein and James Pethokoukis react to the regulatory change by the Treasury on taxes.
CNBC's David Faber provides perspective to the Pfizer and Allergan deal.
CEO Brent Saunders spoke after Pfizer and Allergan terminated their $160B merger because of surprise changes in U.S. tax regulations.
A failed $160 billion merger between Pfizer and Allergan left experts contemplating whether more deals could be hit by new tax rules.
Allergan CEO Brent Saunders discusses going separate ways with Pfizer after new tax rules by the Treasury, and what investors can expect from Allergan's growth.
Allergan CEO Brent Saunders says his company was blindsided by the new tax rules by the Treasury.
Pfizer and Allergan called off their $160 billion merger after Treasury issued new rules aimed at blocking inversions. Allergan CEO Brent Saunders discusses the new tax rules, and what investors can expect from growth at Allergan going forward.
The U.S. government hamstrings American businesses trying to compete overseas, says Grover Norquist, Americans for Tax Reform, sharing his thoughts on the problems with the U.S. tax aversion policy.
CNBC's Eamon Javers reports on the fallout from the Treasury Department's new action to prevent more corporations from fleeing the country to avoid paying their taxes.
It is now official, Pfizer and Allergan are calling off the deal to merge, reports "Squawk Box's" Andrew Ross Sorkin.
CNBC's Meg Tirrell's report on the possible end of a merger between Pfizer and Allergan as tax rules tighten.
The U.S. Justice Department will file a lawsuit as soon as this week to stop Halliburton Co from acquiring smaller rival Baker Hughes Inc.
Guy Look, CFO of Sa Sa International, explains why Hong Kong's tourism market is losing global competitiveness.
Richard Peretz, CFO of UPS, discusses the international considerations of doing business in the light of the current political rhetoric on trade, as well as the company's push to continue to be the preferred shipper for e-commerce.
Results from CNBC's CFO Council Survey show 66.7 percent of chief financial officers thought Donald Trump would win the Republican nomination for president.
Newly merged DowDuPont leads the CNBC IQ 100 Index, which was rebalanced for the third quarter of 2017 on Wednesday.
CNBC IQ100 index-beating the brother market over one year up 22%. Today's leaders include Eastman Chemical, Whirlpool, Exxon Mobil and Broadcom.
The CNBC iq100 index, leading the broader market over one year up 22 percent. Today's leaders include Nabors industries, Allergan, General Motors, Level 3 Communications and Garmin.
A globe-trotting look at the world of investing, from developed Europe and Asia trends to the least-traveled frontier markets.
Unlock the keys to building a successful long-term financial plan: manage your money, grow your money, and protect it.
Covering the full set of tools and strategies for long-term investors: How to take everyday market fluctuations in stride, and when to know it’s time to take action or protect against a major economic shifts.